OS03.6.A Rituximab in primary CNS lymphoma - long term follow-up of the phase III HOVON 105/ALLG NHL 24 Study
OS03.6.A 利妥昔单抗治疗原发性中枢神经系统淋巴瘤——HOVON 105/ALLG NHL 24 III期研究的长期随访
期刊:
影响因子:
doi:10.1152/ajprenal.00466.2009
Wang, Youli; Heilig, Kathleen; Saunders, Thomas; Minto, Andrew; Deb, Dilip K; Chang, Anthony; Brosius, Frank; Monteiro, Carmela; Heilig, Charles W; Bromberg, J E C; Issa, S; van der Holt, B; Minnema, M C; Seute, T; Durian, M F; Cull, G; van der Poel, M W M; Stevens, W B C; Zijlstra, J M; Nijland, M; Mason, K D; Beeker, A; Brandsma, D; van den Bent, M J; Gonzalez, M; de Jong, D; Doorduijn, J K